195 related articles for article (PubMed ID: 18314593)
1. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase).
Okada Y
Verh Dtsch Ges Pathol; 2007; 91():29-38. PubMed ID: 18314593
[TBL] [Abstract][Full Text] [Related]
2. ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3.
Mitsui Y; Mochizuki S; Kodama T; Shimoda M; Ohtsuka T; Shiomi T; Chijiiwa M; Ikeda T; Kitajima M; Okada Y
Cancer Res; 2006 Oct; 66(20):9913-20. PubMed ID: 17047053
[TBL] [Abstract][Full Text] [Related]
3. ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis.
Ohtsuka T; Shiomi T; Shimoda M; Kodama T; Amour A; Murphy G; Ohuchi E; Kobayashi K; Okada Y
Int J Cancer; 2006 Jan; 118(2):263-73. PubMed ID: 16052521
[TBL] [Abstract][Full Text] [Related]
4. Binding of ADAM28 to P-selectin glycoprotein ligand-1 enhances P-selectin-mediated leukocyte adhesion to endothelial cells.
Shimoda M; Hashimoto G; Mochizuki S; Ikeda E; Nagai N; Ishida S; Okada Y
J Biol Chem; 2007 Aug; 282(35):25864-74. PubMed ID: 17597069
[TBL] [Abstract][Full Text] [Related]
5. ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3.
Mochizuki S; Shimoda M; Shiomi T; Fujii Y; Okada Y
Biochem Biophys Res Commun; 2004 Feb; 315(1):79-84. PubMed ID: 15013428
[TBL] [Abstract][Full Text] [Related]
6. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression.
Lucas N; Day ML
J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865
[TBL] [Abstract][Full Text] [Related]
7. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
[TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
12. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility.
Massoner P; Colleselli D; Matscheski A; Pircher H; Geley S; Jansen Dürr P; Klocker H
Endocr Relat Cancer; 2009 Sep; 16(3):795-808. PubMed ID: 19509068
[TBL] [Abstract][Full Text] [Related]
14. [Research advances on ADAM28 expression and ADAM28-mediated tumor metastasis].
Zhu XL; Wang QM; Feng FE; Zheng XL; Zhang XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1142-7. PubMed ID: 25130845
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
Kawada M; Inoue H; Arakawa M; Ikeda D
Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
[TBL] [Abstract][Full Text] [Related]
16. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
[TBL] [Abstract][Full Text] [Related]
17. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
van Hinsbergh VW; Koolwijk P
Cardiovasc Res; 2008 May; 78(2):203-12. PubMed ID: 18079100
[TBL] [Abstract][Full Text] [Related]
18. Soluble adhesion molecules in human cancers: sources and fates.
van Kilsdonk JW; van Kempen LC; van Muijen GN; Ruiter DJ; Swart GW
Eur J Cell Biol; 2010 Jun; 89(6):415-27. PubMed ID: 20227133
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer.
Yamada D; Ohuchida K; Mizumoto K; Ohhashi S; Yu J; Egami T; Fujita H; Nagai E; Tanaka M
Anticancer Res; 2007; 27(2):793-9. PubMed ID: 17465204
[TBL] [Abstract][Full Text] [Related]
20. Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.
Mochizuki S; Soejima K; Shimoda M; Abe H; Sasaki A; Okano HJ; Okano H; Okada Y
J Natl Cancer Inst; 2012 Jun; 104(12):906-22. PubMed ID: 22636800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
